Dysadherin specific drug conjugates for the treatment of thyroid cancers with aggressive phenotypes

Samuel Jang(WinnMed), Herbert Chen(University of Alabama at Birmingham)
Oncotarget
January 30, 2017
Cited by 6


Related Papers